IONTOX works with a global client base on ADME-PK and toxicology based in vitro research.
Download the In Vitro Services Catalog
About IONTOX
In 2013 the Editor and Chief of Applied In Vitro Toxicology James McKim, Ph.D., D.A.B.T., founded IONTOX to support his contacts in the pharmaceutical, chemical, food additive, and cosmetic industries.
IONTOX follows GIVIMP and GCCP guidelines.
Proprietary Technology
An in vitro system for understanding compound drug and chemical movement in multiple organs.
Using the Human Dynamic Multiple Organ Plate (HuDMOP)TM gives clients the ability to integrate two to six organ systems when running in vitro studies.
Regulatory Compliance
Regulatory guidelines followed by IONTOX
GLP Followed
GCCP Guidelines Followed
DEA Schedule I - IV Licensed
Advanced In Vitro Research
Do advanced in vitro research
Cytotoxicity
Study cell toxicity
ADME -PK In Vitro
Study Absorption, distribution, metabolism, excretion, and pharmacokinetics.
3D Tissue Testing
Study how your compound effects advanced 3D tissue models.
